Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis

SAN DIEGO–(BUSINESS WIRE)–Illumina and BeSolveRD will study the clinical utility and health economic impact of WGS of patients with intellectual disabilities.
Click here to view original post